QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.5 % of QIAGEN's outstanding common shares at the end of 2016.
|Franklin Resources, Inc., United States||25,700||11.13|
|BlackRock, Inc., United States||19,500||8.45|
|PRIMECAP Management Company, United States||19,143||8.29|
Status: March 2017